Didn't Teva also raise the Copaxone price at the beginning of 2012 by 15% as well? Now another 10% in 2013. That's about a 100% increase since 2010. Maybe the silver lining for each year MNTA is delayed in approval-- Teva keeps growing the market via price increases.... Let's hope MNTA's manufacturing process is at least as efficient to allow for 90% margins as well.
Market Data 
Markets
AI
